World's Best Scientists 2026 revealed!
Matti Lehtinen

Matti Lehtinen

D-Index & Metrics

Microbiology

D-Index
75
Citations
30093
World Ranking
1471
National Ranking
15

Medicine

D-Index
83
Citations
33231
World Ranking
15419
National Ranking
176

Matti Lehtinen publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Matti Lehtinen sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 300 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Matti Lehtinen D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Matti Lehtinen sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 75 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2012 - Fellow of Alfred P. Sloan Foundation

Overview

Matti Lehtinen is affiliated with Tampere University in Finland and has a significant body of research in Medicine, focusing primarily on Epidemiology, Surgery, Immunology, Microbiology, and Animal Science and Zoology. Their most frequent area of study is Cervical Cancer and HPV Research, supplemented by work on Hepatitis B Virus Studies, Genital Health and Disease, Immunotherapy and Immune Responses, Reproductive Tract Infections Research, Animal Virus Infections Studies, and Head and Neck Cancer Studies.

The scientist's recent publications include:

  • Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials, 2021, The Lancet Infectious Diseases
  • Impact of HPV vaccination on cervical screening performance: a population-based cohort study, 2020, British Journal of Cancer
  • Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied, 2020, The Journal of Infectious Diseases
  • Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines, 2020, npj Vaccines
  • Human Papillomavirus Genotype Replacement: Still Too Early to Tell?, 2020, The Journal of Infectious Diseases

Key frequent co-authors of Matti Lehtinen comprise Tiina Eriksson, Joakim Dillner, Penelope Gray, Ville N. Pimenoff, and Simopekka Vänskä.

The researcher regularly publishes in several academic venues, with the most frequent being the International Journal of Cancer, The Journal of Infectious Diseases, Preventive Medicine, npj Vaccines, and BMJ Open.

Matti Lehtinen has also contributed to book publications, including the title "Human Papillomavirus Vaccination and Screening in the Elimination of HPV-Associated Cancers: Evidence-Based Randomized Trials," published in 2024 by BENTHAM SCIENCE PUBLISHERS eBooks.

Among the recognitions received is the status of Fellow of the Alfred P. Sloan Foundation awarded in 2012.

Best Publications

  • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

    Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen

  • Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

    J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler

  • Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade

  • Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

    Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud

  • Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck

    Mork J;Lie Ak;Glattre E;Hallmans G

  • Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn

  • High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

    L. L. Villa;R. L. R. Costa;C. A. Petta;R. P. Andrade

  • Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Cosette M. Wheeler;Xavier Castellsagué;Suzanne M. Garland;Anne Szarewski

  • Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

    Luisa L. Villa;Kevin A. Ault;Anna R. Giuliano;Ronaldo L.R. Costa

  • Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.

    Tarja Anttila;Pekka Saikku;Pentti Koskela;Aini Bloigu

  • Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.

    Pentti Tuohimaa;Leena Tenkanen;Merja Ahonen;Sonja Lumme

  • Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

    Sven-Eric Olsson;Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta

  • Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

    Pentti Koskela;Tarja Anttila;Tone Bjørge;Anne Brunsvig

  • Seroepidemiology of the human polyomaviruses.

    Annika Stolt;Kestutis Sasnauskas;Pentti Koskela;Matti Lehtinen

  • Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses

    Ruanne V Barnabas;Ruanne V Barnabas;Päivi Laukkanen;Pentti Koskela;Osmo Kontula

  • A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions

    Susanne K. Kjaer;Kristján Sigurdsson;Ole-Erik Iversen;Mauricio Hernandez-Avila

  • Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.

    Joakim Dillner;Joakim Dillner;Susanne K. Kjaer;Cosette M. Wheeler;Kristján Sigurdsson

  • Three factor eating questionnaire-R18 as a measure of cognitive restraint, uncontrolled eating and emotional eating in a sample of young Finnish females

    Susanna Anglé;Janne Engblom;Tiina Eriksson;Susanna Kautiainen

  • Immunization of Early Adolescent Females with Human Papillomavirus Type 16 and 18 L1 Virus-Like Particle Vaccine Containing AS04 Adjuvant

    Court Pedersen;Tiina Petaja;Gitte Strauss;Hans C. Rumke

  • Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S‐phase fraction: A proposed classification of DNA histograms in breast cancer

    Olli-Pekka Kallioniemi;Guillermo Blanco;Martti Alavaikko;Tenho Hietanen

Frequent Co-Authors

Jorma Paavonen
Jorma Paavonen University of Helsinki
Joakim Dillner
Joakim Dillner Karolinska University Hospital
Eero Pukkala
Eero Pukkala Tampere University
Suzanne M. Garland
Suzanne M. Garland University of Melbourne
Gary Dubin
Gary Dubin GlaxoSmithKline (United Kingdom)
Göran Hallmans
Göran Hallmans Umeå University
Cosette M. Wheeler
Cosette M. Wheeler University of New Mexico
Xavier Castellsagué
Xavier Castellsagué University of Barcelona
F. Xavier Bosch
F. Xavier Bosch Open University of Catalonia
Paolo Toniolo
Paolo Toniolo New York University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, exploring online healthcare degrees that pay well can open doors to a variety of high-demand roles. Degrees in healthcare fields often complement microbiology knowledge and lead to rewarding careers in medical research, diagnostics, and public health.

If you're considering advancing your education with a public health focus, finding the best easiest mph online programs to get into can be a strategic option. These programs provide foundational skills in epidemiology and health policy, highly relevant for microbiology professionals aiming to impact community health.

Some microbiology graduates pivot towards specialized roles like becoming a child life specialist. This career not only offers personal fulfillment but also competitive compensation, as detailed in the child life specialists salary guide. Understanding such pathways can help tailor your career trajectory effectively.

Additionally, for individuals with unique backgrounds or challenges, such as those with felony records, it’s encouraging to know there are degrees for felons that can launch new professional beginnings. These options underscore the accessibility of online education in microbiology-related fields for diverse learners.

Best Scientists Citing Matti Lehtinen

Trending Scientists

Recently Published Articles